Uduak Grace Thomas
Uduak Grace Thomas covers bioinformatics, computational biology, and life science informatics for GenomeWeb. Follow her on Twitter at @UduakGW.
Articles Authored by Uduak Grace Thomas
The consortium will gather Nigerians' genomic, phenotypic, and clinical data in six geopolitical regions to study non-communicable and infectious diseases.
DNAnexus PrecisionFDA Platform Expansion Will Add Support for Multi-Omics Data, Interactive Review
Premium
In addition to developing standards for proteomics, metabolomics, and other kinds of data, DNAnexus will develop tools to help reviewers quickly and easily assess analysis pipelines.
The company uses systems biology approaches and AI methods to model and analyze causal pathways in diseases including neurological cancers and Alzheimers.
The standards address ongoing data analysis issues including ways of securely sharing and analyzing genomic information across platforms and mechanisms for consistently identifying sequences.
Project partners will expand on infrastructure developed by DNAstack for accessing genomic data and explore patient consent models that support nationwide sharing.
MMRF to Bolster Recently Launched Clinical, Genomic Patient Data Registry With Immune Profiles
Premium
Data from MMRF's Immune Atlas will be included in its recently launched CureCloud, a registry of clinical, genomic, and EHR data from multiple myeloma patients.
Metascape uses data from over 40 knowledgebases and 10 model organisms to provide functional enrichment, interactome analysis, gene annotation, and membership search capabilities.
DARTS uses deep learning-based techniques to leverage public RNA-sequencing datasets to make predictions about alternative splicing in individuals datasets.
Viome Shares First Details of DTC Microbiome Technology as Research Community Weighs Evidence
Premium
The company shared details of its methods and results of some internal experiments but has been met with skepticism by members of the research community.
New Memorial Sloan Kettering Tool Simplifies Curation of Germline Variants Using ACMG Guidelines
Premium
MSK's PathoMAN achieved 94 percent and 81 percent concordance with results from three commercial labs for pathogenic and benign variants, respectively.